Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses

Clinical and Experimental Allergy

Volumn 26, Issue 1, 1996, Pages 68-78

  Taborda Barata, L ^a   Jacobson, M ^a   Walker, S ^a   Njuki, F ^a   Ying, S ^a   Randev, P ^a   Durham, S R ^a   Kay, A B ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cetrizine; Eosinophil; Granulocyte macrophage colony stimulating factor; Interleukin 3; Interleukin 4; Interleukin 5; Late phase response; Prednisolone; TH2 cytokine

Indexed keywords

ALLERGEN; CETIRIZINE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; PREDNISOLONE;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EOSINOPHIL; HELPER CELL; HUMAN; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; SKIN BIOPSY; T LYMPHOCYTE;

ADULT; ALLERGENS; CETIRIZINE; CHEMOTAXIS, LEUKOCYTE; CROSS-OVER STUDIES; CYTOKINES; DOUBLE-BLIND METHOD; EOSINOPHILS; HUMANS; HYPERSENSITIVITY, DELAYED; IN SITU HYBRIDIZATION; MIDDLE AGED; PREDNISOLONE; RNA, MESSENGER; SKIN TESTS;

EID: 0030053084     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00058.x     Document Type: Article

References (35)

1. Varney V, Gaga M, Frew AJ, De Vos C, Kay AB. The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen-induced cutaneous late-phase reactions in atopic subjects. Clin Exp Allergy 1992; 22:43-9.
2. Kontou-Fili K, Paleologos G, Herakleous M. Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl. Eur J Clin Pharmacol 1989; 36:617-9.
3. Campoli-Richards DM, Buckley MMT, Fitton A. Cetirizine: a review of its pharmacological properties and clinical importance in allergic rhinitis, pollen-induced asthma and chronic urticaria. Drugs 1990; 40:762-81.
4. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of cetirizine on mast cell mediator release and cellular traffic during the cutaneous late phase reaction. J Allergy Clin Immunol 1989; 83:905-12.
5. Fadel R, Herpin-Richard N, Rihoux JP, Henocq E. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 1986; 17:373-8.
6. Pipkorn U, Hammarlund A, Enerback L. Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen-induced weal-and-flare response and a reduction in skin mast cell numbers and histamine content. Clin Exp Allergy 1989; 19:19-25.
7. Poothullil J, Umemoto L, Dolovich J, Hargreave FE, Day RP. Inhibition by prednisone of late cutaneous allergic responses induced by anti-serum to human IgE. J Allergy Clin Immunol 1976; 57:164-7.
8. Gin W, Shaw RJ, Kay AB. The effect of corticosteroids on monocyte and neutrophil activation in bronchial asthma. J Allergy Clin Immunol 1985; 76:675-83.
9. Schleimer RP. The effect of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990; 141:859-869.
10. Gillis S, Crabtree GR, Smith KA. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 1979; 123:1624-31.
11. Masuyama K, Jacobson MR, Rak S et al. Topical glucocorticosteroid (fluticasone dipropionate) inhibits cytokine mRNA expression for interleukin-4 (IL-4) in the nasal mucosa in allergic rhinitis. Immunology 1994; 82:192-9.
12. Rolfe FG, Hughes JM, Armour CL, Sewell WA. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 1992; 77:494-9.
13. Wu CY, Fargeas C, Nakajima T, Delespesse G. Glucocorticoids suppress the production of interleukin-4 by human lymphocytes. Eur J Immunol 1991; 21:2645-7.
14. Robinson DS, Hamid Q, Ying S et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5 and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993;148:401-6.
15. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988; 141:4158-64.
16. Kay AB, Ying S, Varney V et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte, macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173:775-8.
17. Tsicopoulos A, Hamid Q, Haczku A et al. Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J Allergy Clin Immunol 1994; 94:764-72.
18. Gaga M, Frew AJ, Varney V, Kay AB. Eosinophil activation and T lymphocyte infiltration in allergen-induced late-phase skin reactions and classical delayed-type hypersensitivity. J Immunol 1991; 147:816-22.
19. Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and GM-CSF in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390-4.
20. Robinson DS, Hamid Q, Bentley A et al. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in atopic asthmatics. J Allergy Clin Immunol 1993; 92:313-24.
21. Dolovich J, Hargreave FE, Chalmers R et al. Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 1973; 52:38-46.
22. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1977; 58:408-20.
23. Schleimer RP, Sterbinsky SA, Kaiser J et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992; 148:1086-92.
24. Noelle R, Krammer PH, Ohara J, Uhr JW, Vitetta ES. Increased expression of Ia antigens on resting B cells. An additional role for B-cell growth factor. Proc Natl Acad Sci USA 1984; 81:6149-55.
25. Zlotnick A, Daine B, Ransom J, Zipori D. Effects of recombinant B cell growth factor 1 on a macrophage cell line. J Leuk Biol 1986; 40:314-8.
26. Lopez AF, Sanderson CJ, Gamble JR et al. Recombinant human interleukin-5 is a selective activator of eosinophil function. J Exp Med 1988; 167:219-24.
27. Lopez AF, Elliott MJ, Woodcock J, Vadas MA. GM-CSF, IL-3 and IL-5: cross competition on human haemopoietic cells. Immunol Today 1992; 13:495-500.
28. Rothenberg ME, Petersen J, Stevens RL et al. IL-5 dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity and sustained antibody-dependent cytotoxicity. J Immunol 1989; 143:2311-6.
29. Bos JD, De Boer OJ, Tibosch E, Das PK, Pals ST. Skin-homing T lymphocytes: detection of cutaneous lymphocyte-associated antigen (CLA) by HECA-452 in normal human skin. Arch Dermatol Res 1992; 285:179-83.
30. Her E, Austen KF, Owen WF. Dexamethasone attenuates the survival of eosinophils co-cultured with endothelial cells by effects on both eosinophils and endothelial cells. J Allergy Clin Immunol 1991; 87:172 abstr.
31. Michel L, De Vos C, Rihoux JP et al. Inhibitory effect of oral cetirizine on in vivo antigen induced histamine and PAF-acether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988; 82:101-9.
32. Walsh GM, Moqbel R, Hartnell A, Kay AB. The effect of cetirizine on human eosinophil and neutrophil activation in vitro. Int Arch Allergy Appl Immunol 1991; 95:158-62.
33. Brusselle GG, Kips JC, Tavernier JH et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994; 24:73-80.
34. Nakajima H, Iwamoto I, Tomoe S et al. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992; 146:374-7.
35. Van Oosterhout AJ, Ladenius AR, Savelkoul HF et al. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993; 147:548-52.